Hope against breast cancer

There is new hope in the fight against breast cancer.

Scientists have found that silencing the BCL-2 gene in oestrogen receptor positive cancer sufferers makes the cancer more responsive to chemotherapy treatment.

70% of breast cancer sufferers are diagnosed with oestrogen receptor positive cancer.

The research found a diagnostic marker in the blood, potentially making cancer detectable.

Read more at Garvan Institute of Medical Research & Cardiff University

Expert Database

Want to write?

Write an article and join a growing community of more than 57,600 academics and researchers from 2,183 institutions.

Register now